News
03-01-2010, 01:57 AM
The Board of Directors of Ipsen, chaired by Jean-Luc Bélingard, met on 26 February 2010 to review the Group’s results for 2009, published today.
More... (http://www.news-medical.net/news/20100301/Ipsene28099s-2009-performance-Azzalure-Dysport-and-Decapeptyl-approval-Adenuric-partnership-drug-sales-up-7625.aspx)
More... (http://www.news-medical.net/news/20100301/Ipsene28099s-2009-performance-Azzalure-Dysport-and-Decapeptyl-approval-Adenuric-partnership-drug-sales-up-7625.aspx)